Legend Biotech Corporation Share Price

Legend Biotech Corporation Share Price

NASDAQ: LEGN
$21.64
-$0.66 (-2.96%) Last updated on 31 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Legend Biotech Corporation Stock Performance

Open
$22.02
Prev. Close
$22.30
Circuit Range
N/A
Day Range
$21.36 - $22.36
Year Range
$16.26 - $37.28
Volume
81,613
Average Traded
$21.73

Legend Biotech Corporation Share Price Today

As of 31 October 2026, Legend Biotech Corporation's share price is $21.64. The stock opened at $22.02, compared to its previous close of $22.30. During today's trading session, Legend Biotech Corporation's share price traded between $21.36 and $22.36, with an average price of $21.86. Over the past 52 weeks, the stock has recorded a high of $37.28 and a low of $16.26. In terms of performance, Legend Biotech Corporation's share price has declined by 8.05% over the last six months and is down 33.19% on a year-on-year basis.

Legend Biotech Corporation Share Price Chart

Line chart of the Legend Biotech Corporation price trend over the selected period. The price fell overall, ranging from 21.35 to 22.36, ending at 21.62.
$21.36$22.36
L
Show Current Price
H

Legend Biotech Corporation Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$1.03T
Return On Equity (TTM)
N/A
Profit Margin
-28.85%
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

Legend Biotech Corporation Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$117.01$285.10$627.30$1028.90
Net Profit-$446.35-$518.30-$177.00-$296.80
Net Profit Margin-381.46%-181.80%-28.22%-28.85%
Income ChangeN/A-16.12%65.85%-67.68%

About Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Legend Biotech Corporation Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$19.70
$21.64
+8.86%
Sep 2026
$20.80
$19.88
-3.05%
Aug 2026
$18.57
$20.50
+10.60%
Jul 2026
$29.00
$18.54
-35.77%
Jun 2026
$26.21
$28.86
+6.36%
May 2026
$23.43
$27.13
+15.28%
Apr 2026
$18.35
$23.54
+30.14%
Mar 2026
$18.56
$18.09
-4.84%
Feb 2026
$17.51
$19.00
+8.57%
Jan 2026
$21.52
$17.50
-19.52%
Dec 2025
$27.35
$21.75
-21.45%
Nov 2025
$32.60
$27.69
-14.51%

LEGN Share Price FAQs